Revenue and earnings by business segment

Social Media

Related Links

Share Price

Data is delayed by 15 minutes.

Library

Contact

Fresenius SE & Co. KGaA
Investor Relations
+49 (0) 6172 608-2485
ir-fre@fresenius.com

In 2024, we expect revenue and earnings development in our business segments as shown in the table below:

Operating Companies	Targets 2024	Base 2023²
Fresenius Kabi
Revenue growth (organic)	Mid-single-digit percentage growth	€8,009 m
EBIT margin¹	Around 15% (structural margin band: 14-17%)	€1,145 m
Fresenius Helios
Revenue growth (organic)	Low-to-mid-single-digit percentage growth	€11,952 m
EBIT margin¹	Within the structural margin band of 9-11%	€1,190 m
Investment Company Fresenius Vamed
Revenue growth (organic³)	Mid-single-digit percentage growth	€2,201 m
EBIT margin¹	1-2 percentage points below the structural margin band of 4-6%	-€16 m
¹Before special items
²Base 2023 adjusted
³Calculated for continued business

	Achieved 2023	Portfolio adjustment Fresenius Helios	Discontinued business Fresenius Vamed²	Base Guidance 2024
Group
Revenue	€22,299 million	-€368 million	-€155 million	€21,776 million
EBIT¹	€2,262 million	-€42 million	€0 million	€2,220 million
Operating Companies
Fresenius Kabi
Revenue	€8,009 million			€8,009 million
EBIT¹	€1,145 million			€1,145 million
Fresenius Helios
Revenue	€12,320 million	-€368 million		€11,952 million
EBIT¹	€1,232 million	-€42 million		€1,190 million
Investment Company
Fresenius Vamed
Revenue	€2,356 million		-€155 million	€2,201 million
EBIT¹	-€16 million		€0 million	-€16 million
Corporate
Revenue	-€386 million			-€386 million
EBIT¹	-€99 million			-€99 million
¹Before special items
²Existing projects in respective countries will continue for a certain time period

Social Media

Topic filter